
Silymar - tablets:
1 tab. contains silimara dry extract (milk thistle dry extract) 100 mg; 30 pieces packaged.
Hepatoprotective. Silymar inhibits cytolysis, inhibits the growth of indicator enzymes (ALT, AST, alkaline phosphatase, gamma-glutamate transferase), and prevents the development of cholestasis.
Hepatitis of various genesis, liver cirrhosis, toxic liver damage (including medicinal, alcoholic, heavy metal compounds), fatty hepatosis.
Individual intolerance.
Not identified.
Silimar is taken orally, 30 minutes before a meal, 1-2 tablets. 3 times a day, for 25-30 days. If necessary, repeat the treatment after 1-3 months.
In a dry, dark place at a temperature of no higher than 25 ° C.